维普中文期刊产品整合服务
34篇 您的检索式:作者名="O’Morain"
    题名 作者 年代 出处 被引量
1Nutritional therapy in inflammatory bowel diseas显示文摘Maria O’Sullivan Colm O’Morain 2004Current Treatment Options in Gastroenterology2004,,3:1
2Bacterial supplementation in the irritable bowel syndrome. A randomised doubleblind placebo-controlled crossover study显示文摘M.A. O’Sullivan C.A. O’Morain 2000Digestive and Liver Disease2000,,4:1
3Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance显示文摘The gram-negative bacterium Helicobacter pylori(H.pylori)causes chronic gastritis,gastric and duodenal ulcers,gastric cancer and mucosa-associated lymphoid tissue lymphoma.Treatment is recommended in all symptomatic patients.The current treatment options for H.pylori infection are outlined in this review in light of the recent challenges in eradication success,largely due to the rapid emergence of antibiotic resistant strains of H.pylori.Antibiotic resistance is a constantly evolving process and numerous studies have shown that the prevalence of H.pylori antibiotic resistance varies significantly from country to country,and even between regions within the same country.In addition,recent data has shown that previous antibiotic use is associated with harbouring antibiotic resistant H.pylori.Local surveillance of antibiotic resistance is warranted to guide clinicians in their choice of therapy.Antimicrobial resistance is assessed by H.pylori culture and antimicrobial susceptibility testing.Recently developed molecular tests offer an attractive alternative to culture and allow for the rapid molecular genetic identification of H.pylori and resistance-associated mutations directly from biopsy samples or bacterial culture material.Accumulating evidence indicates that surveillance of antimicrobial resistance by susceptibility testing is feasible and necessary to inform clinicians in their choice of therapy for management of H.pylori infection.Sinéad M Smith Colm O’Morain Deirdre McNamara 2014World Journal of Gastroenterology2014,20,29:40
4Nature meets nurture: molecular genetics of gastric cancer显示文摘Anya N. Milne F. Carneiro C. O’Morain G. J. A. Offerhaus 2009Human Genetics2009,,5:4
5Treatment of H elicobacter pylori Infection 2013显示文摘Anthony O’Connor Javier Molina‐Infante Javier P. Gisbert Colm O’Morain 2013Helicobacter2013,,:2
6Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results显示文摘S Sebastian R McLoughlin A Qasim C.A O’Morain M.J Buckley 2003Digestive and Liver Disease2003,,3:1
7Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report显示文摘MALFERTHEINER P MEGRAUD F O’MORAIN C A 2012Gut2012,61,:1
8Current concepts in the management of Helicobacter pylori infection:the MaastrichtⅢConsensus Report显示文摘Malfertheiner P Meqraud F O’Morain C 2007Gut2007,56,6:1
9Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology显示文摘Grainne Holleran Ronan Leen Colm O’Morain Deirdre McNamara 2014Endoscopy2014,,07:1
10Management of Helicobacter Pylori Infection--the Maastricht IV/Florence Consensus Report显示文摘Malfertheiner P Megraud F O’Morain CA 2012Gut2012,61,5:1
11Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results显示文摘S Sebastian R McLoughlin A Qasim C.A O’Morain M.J Buckley 2003Digestive and Liver Disease2003,,3:1
12Increased mast cells in the irritable bowel syndrome [This paper]显示文摘O’Sullivan Clayton Breslin Harman Bountra Mclaren O’Morain 2001Neurogastroenterology & Motility2001,,5:1
13Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus report显示文摘Malfertheiner P Megraud F O’Morain CA 2012Gut2012,61,5:1
14Current concepts in the management of Helicobacter pylori infection:the Maastricht III Consensus Report显示文摘Malfertheiner P Megraud F O’Morain C 2007Gut2007,56,6:1
15Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report显示文摘Malfertheiner P Megraud F O’Morain CA 2012GUT2012,61,:1
16Percutaneous endoscopic gastrostomy — its application in patients with neurological disease显示文摘S. M. Sant J. Gilvarry R. Shannon C. O’Morain 1993Irish Journal of Medical Science1993,,11:1
17Nature meets nurture: molecular genetics of gastric cancer显示文摘Anya N. Milne F. Carneiro C. O’Morain G. J. A. Offerhaus 2009Human Genetics2009,,5:1
18Nutritional treatments in inflammatory bowel disease显示文摘Maria O’Sullivan BSc PhD Colm O’Morain MD MSc DSc FRCPI 2001Current Treatment Options in Gastroenterology2001,,3:1
19Management of Helicobacter pylori infection-the MaastrichtⅣ/Florence Consensus Report显示文摘Malfertheiner P Megraud F O’Morain CA et a1 2012Gut2012,61,5:1
20Vitamin D deficiency in Crohn’s disease: Prevalence, risk factors and supplement use in an outpatient setting显示文摘Treasa Nic Suibhne Gerry Cox Martin Healy Colm O’Morain Maria O’Sullivan 2011Journal of Crohn’s and Colitis2011,,2:3
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费